Entry
Name
Definition
NNK -- (AKR1C2,CBR1,HSD11B1) >> (CYP2A6,CYP2A13) -> C19580 -> C19581 == DNA
Expanded
C16453 -- (1646,873,3290) >> (1548,1553) -> C19580 -> C19581 == C00039
Class
nt06250 DNA adduct formation (cancer)
Type
Env factor
Pathway
hsa05204 Chemical carcinogenesis - DNA adducts
Disease
H00014 Non-small cell lung cancer
Gene
1646 AKR1C2; aldo-keto reductase family 1 member C2
873 CBR1; carbonyl reductase 1
3290 HSD11B1; hydroxysteroid 11-beta dehydrogenase 1
1548 CYP2A6; cytochrome P450 family 2 subfamily A member 6
1553 CYP2A13; cytochrome P450 family 2 subfamily A member 13
Perturbant
C16453 (NNK) 4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone
Metabolite
C19580 alpha-[3-[(Hydroxymethyl)nitrosoamino]propyl]-3-pyridinemethanol
C19581 alpha-[3-(Nitrosoamino)propyl]-3-pyridinemethanol
Reference
Authors
Chiang HC, Wang CY, Lee HL, Tsou TC
Title
Metabolic effects of CYP2A6 and CYP2A13 on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced gene mutation--a mammalian cell-based mutagenesis approach.
Journal
Reference
Authors
Bhat SH, Gelhaus SL, Mesaros C, Vachani A, Blair IA
Title
A new liquid chromatography/mass spectrometry method for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine.
Journal
LinkDB
All DBs